Nonhuman Primate Studies Coordination Center (NHP CC) to Support COVID-related Research at the National Primate Research Centers (NPRCs)

为了应对与COVID-19大流行相关的国家紧急状态以及优先研究以支持加速COVID-19治疗干预和疫苗（ACTIV）的需要，国家过敏和传染病研究所（NIAID）将建立一个非人类灵长类动物研究协调中心（NHP CC），以帮助分配，管理，以及协调七个国家灵长类动物资源中心（NPRC）的COVID非人灵长类动物（NHP）研究。这一国家方案审查委员会网络将直接支持“行动倡议”四个快速重点领域中的三个。 1. 在开放的论坛上标准化和共享临床前评价方法，以便进行比较和验证。 2. 优先考虑并加速具有近期潜力的治疗候选药物的临床评估。 3. 推进疫苗研发。 NHP CC应协调每个非人灵长类动物COVID治疗和疫苗评估单位（NHP CoTVEU）的活动，并在各方之间建立沟通渠道。

In response to the National Emergency related to the COVID-19 pandemic and the need to prioritize studies to support the Acceleration of COVID-19 Therapeutic Interventions and Vaccines (ACTIV), the National Institute of Allergy and Infectious Disease (NIAID) will establish a Nonhuman Primate Studies Coordination Center (NHP CC) to aid in the distribution, administration, and coordination of COVID Nonhuman Primate (NHP) studies across the seven National Primate Resource Centers (NPRCs). This network of NPRCs will directly support three of the four fast-track focus areas in ACTIV. 1. Standardize and share preclinical evaluation methods in an open forum that allows for comparison and validation. 2. Prioritize and accelerate clinical evaluation of therapeutic candidates with near-term potential. 3. Advance vaccine development. The NHP CC shall coordinate activities at each Nonhuman Primate COVID Therapeutics and Vaccine Evaluation Unit (NHP CoTVEU) and establish lines of communications among all parties.